NervGen Pharma Reports Second Quarter 2022 Results and Provides Corporate Update
Cash position enhanced by over $22 million due to private placement and exercise of warrants and options Dosing in third dose cohort of multiple ascending dose (MAD) portion of Phase 1 clinical trial ongoing Discussions ongoing with FDA regarding partial clinical hold Update provided on developments with US Government related to non-dilutive funding in spinal […]
Dos and Don’ts of Listening to Podcasts About Your Condition
By Codi Darnell August 9, 2022 The podcast world has exploded. Whether it’s your next-door neighbour or your favourite celebrity, it suddenly feels as though everyone is streaming themselves onto the platform. The topics are wide-ranging and seemingly endless, and any listener can be satisfied whether they’re after true crime, children’s stories, or something in […]
NervGen Presenting Study Design for Upcoming Phase 1b/2a in Alzheimer’s Disease at the 2022 Alzheimer’s Association International Conference
Vancouver, Canada August 2, 2022 – NervGen Pharma Corp., (TSX-V: NGEN) (OTCQX: NGENF), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, will present the study design for its upcoming Phase 1b/2a Alzheimer’s disease clinical trial at the 2022 Alzheimer’s Association International Conference (AAIC) on August 3, 2022. […]
Making Beaches More Accessible
By Codi Darnell July 26, 2022 Nothing screams summer quite like a day at the beach. There are beaches covering thousands of miles of coastline around the world, and even more that surround the lakes and rivers further inland. In any beach town, both locals and tourists flock to sandy shores for everything from suntanning […]
Music Therapy at Home
By Codi Darnell July 12, 2022 Music is everywhere. It plays at home, at work, in shopping malls, elevators, and over and over in our heads (sometimes at the most inopportune moments). People turn to different genres and artists for different moods and situations, and parents make up silly songs to get their kids to […]
NervGen Pharma Corp. Announces US$15MM Non-Brokered Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada. June 30, 2022— NervGen Pharma Corp. (TSX-V: NGEN; OTCQX: NGENF) (“NervGen” the “Company”), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, is pleased to announce that it has entered into […]
The Importance of Dignity in Caregiving
By Codi Darnell June 28, 2022 “Dignity is as essential to human life as water, food, and oxygen.” – Laura Hillenbrand I was 28 years old the first time a care-aid showered me. Just days after surgery, newly paralyzed, and unfamiliar with my own body, it was the first time in my adult life I […]
In Case I Forget – Support for Alzheimer’s Caregivers
By Codi Darnell April 19, 2022 “My vision for In Case I Forget, LLC is to remember for those who forget and to remind caregivers that they are not alone on this journey.” – Ty Lewis Navigating an Alzheimer’s disease diagnosis with a loved one and deciding on the best course of action when it […]
NervGen Pharma Appoints Craig Thompson to the Board of Directors
30 years of industry experience from CEO of Nasdaq-listed biotech to Vice President, Marketing at Pfizer Experience on 16 development stage products, 15 commercial stage products and numerous pre-clinical assets, in both start-up and large pharmaceutical companies Vancouver, Canada. April 13, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a […]
NervGen Pharma Grants Stock Options
Vancouver, Canada. April 6, 2022 – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech company dedicated to developing a first-in-class neuroreparative drug to treat nervous system damage, announced that the Company has granted 376,000 incentive stock options to Employees and Officers exercisable at a price of $2.06 per […]